Trials / Unknown
UnknownNCT03679702
A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Michael Krychman, MD · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A pilot study to investigate non-surgical treatment for women who suffer from sexual complaints secondary to SSRI Sexuality Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Viveve System | Radiofrequency device utilized in general surgical procedures for electrocoagulation and hemostasis. |
Timeline
- Start date
- 2018-12-15
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2018-09-20
- Last updated
- 2018-11-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03679702. Inclusion in this directory is not an endorsement.